Home › Oropharyngeal Cancer › Tennessee › Knoxville
Oropharyngeal Cancer clinical trials in Knoxville, TN
3 studies for Oropharyngeal Cancer are looking for participants at sites in and around Knoxville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- University of Tennessee Health Science Center, Knoxville
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
RecruitingPhase 3
- Tennessee Cancer Specialists, Knoxville
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- University of Tennessee - Knoxville, Knoxville
Oropharyngeal Cancer trials in other cities
- Chicago, IL9 studies
- Edison, NJ8 studies
- Atlanta, GA7 studies
- New York City, NY7 studies
- St. Louis, MO7 studies
- Omaha, NE7 studies
- Tampa, FL6 studies
- Houston, TX6 studies
- Detroit, MI6 studies
- Baltimore, MD6 studies
- Pittsburgh, PA6 studies
- Los Angeles, CA6 studies
Other studies in Knoxville
- Non-Small Cell Lung Cancer15 studies
- Lung Cancer12 studies
- Obesity10 studies
- Breast Cancer9 studies
- Cancer (all types)8 studies
- Heart Failure7 studies
- Overweight7 studies
- Metastatic Cancer7 studies
- Melanoma6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- COPD5 studies
- High Blood Pressure5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.